NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors

Transl Neurodegener. 2023 Nov 2;12(1):49. doi: 10.1186/s40035-023-00381-x.

Abstract

Cognitive impairment is a multifactorial and multi-step pathological process that places a heavy burden on patients and the society. Neuroinflammation is one of the main factors leading to cognitive impairment. The inflammasomes are multi-protein complexes that respond to various microorganisms and endogenous danger signals, helping to initiate innate protective responses in inflammatory diseases. NLRP3 inflammasomes produce proinflammatory cytokines (interleukin IL-1β and IL-18) by activating caspase-1. In this review, we comprehensively describe the structure and functions of the NLRP3 inflammasome. We also explore the intrinsic relationship between the NLRP3 inflammasome and cognitive impairment, which involves immune cell activation, cell apoptosis, oxidative stress, mitochondrial autophagy, and neuroinflammation. Finally, we describe NLRP3 inflammasome antagonists as targeted therapies to improve cognitive impairment.

Keywords: Antagonists; Cognitive impairment; NLRP3 inflammasome; Neuroinflammation; Pharmacological properties.

Publication types

  • Review

MeSH terms

  • Cognitive Dysfunction* / drug therapy
  • Cytokines
  • Humans
  • Inflammasomes*
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Neuroinflammatory Diseases

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Cytokines